Skip to content
★ Sign in to follow
AB

Advanced Biomed Inc. Stock: price and insider trades · United States

US·Mcap US$3.8MHealth Care

Advanced Biomed Inc.: what insiders have been doing

Advanced Biomed Inc. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). Over the twelve months to 1 November 2026, 2 filings were filed, from 1 insider.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

For context, the typical company on the same exchange (median of 3,173 companies) published 24 filings over the same period, against 2 filings here.

There has been no open-market purchase by an insider of Advanced Biomed Inc. for at least a year.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2026

FY ended June 2026 · cache

US$2.30
Analyst consensus
·
Income statement
RevenueUS$127.6k
EBITDA-US$6.3M-4901% margin
Net incomeUS$6.7M5231.3% margin
Valuation
PER (trailing)1.1x
P/Book0.3x
Balance sheet & cash
Market capUS$3.8M
Total debtUS$126.7k
Free Cash Flow-US$1.9M
Debt / Equity9%
Profitability & ownership
ROE-79.5%
ROA-21.3%
% insiders61.4%
% institutions1.4%
Last declaration on 20 August 2026
Declarations2 total
  • ●
    10% OwnerExecutives
    0SEC
    100,000 sharesCommon Stock par vlaue $0.001SEC:0001079973-26-001162:0
  • ●
    10% OwnerExecutives
    0SEC
    76,225 sharesCommon Stock par vlaue $0.001SEC:0001079973-26-001162:1

2 of 2 declarations

About Advanced Biomed Inc.

Advanced Biomed Inc. is a company listed on the XNAS market, specializing in the development of innovative biomedical solutions. It focuses on the research and commercialization of products aimed at improving healthcare.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations